NCT05322668 - Tolerance of Cyto-selective Difluoroethane-based Cryotherapy | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 17, 2022

Primary Completion Date

February 7, 2022

Study Completion Date

February 7, 2022

Conditions

Solar Lentigo

Interventions

DEVICE

Prototypes (812A-v1), (812C-v1), (812D-v1) and (812F-v1)

"All the subjects will receive all the treatment in the same order.~On each hand 2 devices will be attributed as follow:~* Prototypes (812A-v1) will be applied on an area of the back of the patient's right hand, on healthy skin~* Prototypes (812C-v1) will be applied on an area of the back of the patient's right hand, on healthy skin~* Prototypes (812D-v1) will be applied on an area of the back of the patient's left hand, on healthy skin~* Prototypes (812F-v1) will be applied on an area of the back of the patient's left hand, on healthy skin"

Trial Locations (1)

10014

VIDNOVLENNYA medical center, Zhytomyr